Here, in this review, we aim to outline the recent findings in regard to the involvement of CXCL13–CXCR5 signaling in chronic pain as well as certain neurological diseases, with the focus on how this chemokine signaling regulates neuroimmune interaction and neuroinflammation to contribute to pathogenesis of these diseases. Here, CXCR5 is linked to nervous system disorder.